Zenith Capital Corp. (ZHCLF)

USD 0.0

(0.0%)

Total Debt Summary of Zenith Capital Corp.

  • Zenith Capital Corp.'s latest annual total debt in 2023 was 10.22 Thousand USD , up 130.76% from previous year.
  • Zenith Capital Corp.'s latest quarterly total debt in 2024 Q1 was 11.69 Thousand USD , up 14.41% from previous quarter.
  • Zenith Capital Corp. reported annual total debt of 4431.00 USD in 2022, up 27.36% from previous year.
  • Zenith Capital Corp. reported annual total debt of 3479.00 USD in 2021, up 31.09% from previous year.
  • Zenith Capital Corp. reported quarterly total debt of 4866.00 USD for 2023 Q1, up 9.82% from previous quarter.
  • Zenith Capital Corp. reported quarterly total debt of 6192.00 USD for 2023 Q2, up 27.25% from previous quarter.

Annual Total Debt Chart of Zenith Capital Corp. (2023 - 2012)

Historical Annual Total Debt of Zenith Capital Corp. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 10.22 Thousand USD 130.76%
2022 4431.00 USD 27.36%
2021 3479.00 USD 31.09%
2020 2654.00 USD 350.59%
2019 589.00 USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 401.00 USD 158.71%
2014 155.00 USD 0.0%
2013 - USD -100.0%
2012 7646.00 USD 0.0%

Peer Total Debt Comparison of Zenith Capital Corp.

Name Total Debt Total Debt Difference
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.975%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 99.752%
SQZ Biotechnologies Company 27.47 Million USD 99.963%
Evofem Biosciences, Inc. 43.37 Million USD 99.976%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 99.966%
Mesoblast Limited 118.7 Million USD 99.991%
Propanc Biopharma, Inc. 948.27 Thousand USD 98.922%
Genus plc 233.1 Million USD 99.996%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 99.651%
CNBX Pharmaceuticals Inc. 1.34 Million USD 99.239%
Marizyme, Inc. 18.71 Million USD 99.945%
ContraFect Corporation 2.88 Million USD 99.645%
Nymox Pharmaceutical Corporation 750 Thousand USD 98.637%
PsyBio Therapeutics Corp. 135.48 Thousand USD 92.453%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 99.293%
Intellipharmaceutics International Inc. 2.32 Million USD 99.56%
AXIM Biotechnologies, Inc. 5.65 Million USD 99.819%
MultiCell Technologies, Inc. 202.58 USD -4947.389%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 57.48 Million USD 99.982%
EV Biologics, Inc. 1.49 Million USD 99.316%
Q BioMed Inc. 4.1 Million USD 99.751%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.969%
Neon Bloom, Inc. 630.07 Thousand USD 98.377%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 99.168%
Biomind Labs Inc. 735.54 Thousand USD 98.61%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 171.54 Million USD 99.994%
Oncotelic Therapeutics, Inc. 12.99 Million USD 99.921%
Skye Bioscience, Inc. 4.61 Million USD 99.778%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 98.849%
THC Farmaceuticals, Inc. 141.51 Thousand USD 92.775%
Arch Therapeutics, Inc. 5.87 Million USD 99.826%
IMV Inc. 28.88 Million USD 99.965%
Acro Biomedical Co., Ltd. 25.71 Thousand USD 60.243%
Curative Biotechnology, Inc. 2.25 Million USD 99.547%
GB Sciences, Inc. 1.75 Million USD 99.419%
Alpha Cognition Inc. 1.22 Million USD 99.162%
HST Global, Inc. 98.31 Thousand USD 89.6%
CSL Limited 12.18 Billion USD 100.0%
Halberd Corporation 150 Thousand USD 93.183%
Enzolytics Inc. 996.33 Thousand USD 98.974%
Resverlogix Corp. 6.49 Million USD 99.842%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 477.5 Thousand USD 97.859%
Nuo Therapeutics, Inc. 255.59 Thousand USD 95.999%
argenx SE 20 Million USD 99.949%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.978%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 99.623%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Genscript Biotech Corporation 417.73 Million USD 99.998%
Ember Therapeutics, Inc. 200.61 Thousand USD 94.903%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 99.574%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 95.541%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.985%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 99.662%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 97.157%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 99.95%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD 93.122%
BioStem Technologies, Inc. 4.71 Million USD 99.783%
ONE Bio Corp. 19.71 Million USD 99.948%
Reve Technologies, Inc. 250.18 Thousand USD 95.913%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD 95.889%
Agentix Corp. 50 Thousand USD 79.55%
LadRx Corporation 33.6 Thousand USD 69.574%
Cell Source, Inc. 9.25 Million USD 99.89%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 98.648%
Regen BioPharma, Inc. 756.2 Thousand USD 98.648%
NovAccess Global Inc. 2.19 Million USD 99.535%
Endonovo Therapeutics, Inc. 7.07 Million USD 99.855%
Itoco Inc. 228.37 Thousand USD 95.523%
Rasna Therapeutics, Inc. 210.97 Thousand USD 95.153%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 99.795%
Kadimastem Ltd 891.22 Thousand USD 98.853%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. 401.84 Thousand USD 97.456%
CytoDyn Inc. 30.07 Million USD 99.966%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 97.889%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 97.094%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.869%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD 91.653%
Rebus Holdings, Inc. 310 Thousand USD 96.702%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 99.784%
International Stem Cell Corporation 4.17 Million USD 99.755%
Bioxytran, Inc. 1.92 Million USD 99.469%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD 83.617%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 99.531%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 99.877%
Adhera Therapeutics, Inc. 8.58 Million USD 99.881%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 99.343%
Innovation Pharmaceuticals Inc. 268 Thousand USD 96.185%
Neutra Corp. 54.15 Thousand USD 81.119%
Windtree Therapeutics, Inc. 1.83 Million USD 99.441%
PureTech Health plc 25.51 Million USD 99.96%
Coeptis Therapeutics, Inc. 1.22 Million USD 99.165%
IXICO plc 472.02 Thousand USD 97.834%
IntelGenx Technologies Corp. 15.5 Million USD 99.934%
Gelesis Holdings, Inc. 62.26 Million USD 99.984%
CSL Limited 12.18 Billion USD 100.0%
Cellectis S.A. 92.77 Million USD 99.989%